Den Europæiske Union - dansk - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - fluticason furoate - rhinitis, allergic, seasonal; rhinitis, allergic, perennial - nasal præparater, kortikosteroider - voksne, unge (12 år og derover) og børn (6-11 år). avamys er indiceret til behandling af symptomerne på allergisk rhinitis.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - orlistat - fedme - antiobesity preparations, excl. diætprodukter - alli er indiceret til vægttab hos voksne, der er overvægtige (kropsmasseindeks, bmi, ≥ 28 kg / m2) og bør tages sammen med en mildt hypokalorisk, fedtfattig kost.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - ambrisentan - hypertension, lunge - antihypertensiva, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - eptifibatid - angina, unstable; myocardial infarction - antitrombotiske midler - integrilin er beregnet til brug sammen med acetylsalicylsyre og unfractioneret heparin. integrilin er indiceret til forebyggelse af tidlig myokardieinfarkt i patienter med ustabil angina pectoris eller non-q-tak myokardieinfarkt med den sidste episode af brystsmerter, der forekommer inden for 24 timer og med ekg-forandringer og / eller forhøjet hjerte-enzymer. patienter, der er mest tilbøjelige til at drage fordel af integrilin behandling, er dem, der er i høj risiko for udvikling af myokardieinfarkt inden for de første 3-4 dage efter debut af akut angina symptomer, herunder for eksempel dem, der er tilbøjelige til at gennemgå en tidlig perkutan transluminal koronar angioplastik (ptca).

Den Europæiske Union - dansk - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - belimumab - lupus erythematosus, systemisk - immunosuppressiva - benlysta er angivet som add-on terapi til patienter i alderen 5 år og ældre med en aktiv, autoantibody positive systemisk lupus erythematosus (sle) med en høj grad af sygdommens aktivitet (e. positive anti-dsdna og lave supplement), på trods af standard-terapi. benlysta is indicated in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - lamivudin - hepatitis b, kronisk - antivirale midler til systemisk anvendelse - zeffix is indicated for the treatment of chronic hepatitis b in adults with: , compensated liver disease with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active liver inflammation and / or fibrosis. indledning af behandling med lamivudin bør kun overvejes, når anvendelse af en alternativ antiviral agent med en højere genetisk barriere ikke er tilgængelig eller ikke er hensigtsmæssigt, dekompenseret leversygdom i kombination med en anden agent, uden krydsresistens over for lamivudin.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastiske midler - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - belantamab mafodotin - multipelt myelom - antineoplastiske midler - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - umeclidinium bromid, vilanterol trifenatate - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - anoro ellipta er anført som vedligeholdelse bronkodilaterende behandling til at lindre symptomer i voksne patienter med kronisk obstruktiv lungesygdom (kol).